POET Stock Jumped on $500 Million Deal With Lumilens. Its Financials Have a Long Way to Go.

POET stock surged after securing a $500 million deal with Lumilens, yet financial stability remains uncertain.

Key Points

• The $500 million deal boosts POET's market presence.
• Financial metrics indicate significant room for improvement.
• Investors remain cautious about long-term profitability.